CLM has a development pipeline that integrates Drug + Digital + Device for the treatment of some of the biggest challenges facing global health systems - sleep disorders, hypertension, chronic pain and metabolic disease.
We endorse the UK Department of Health and Social Care code of conduct for data-driven health and care technology, although as our approach and collaborations are international, we apply country-specific adaptations where required.
Current product development April 2019
Our development partners
Partnerships are an important part of our approach, with collaborative, co-development or service partnerships including Orient Pharma, Innovate UK, leading UK research institutions and NHS Teaching Hospitals.